These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


73 related items for PubMed ID: 6369456

  • 1. Blood glucose and serum C-peptide after a single chlorpropamide dose.
    Huupponen R.
    Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):347-50. PubMed ID: 6369456
    [Abstract] [Full Text] [Related]

  • 2. Effects of sulfonylurea on the secretion and disposition of insulin and C-peptide.
    Almér LO, Johansson E, Melander A, Wåhlin-Boll E.
    Acta Med Scand Suppl; 1981 Feb; 656():11-8. PubMed ID: 7046346
    [Abstract] [Full Text] [Related]

  • 3. Influence of sulfonylureas on the secretion, disposal and effect of insulin.
    Almér LO, Johansson E, Melander A, Wåhlin-Boll E.
    Eur J Clin Pharmacol; 1982 Feb; 22(1):27-32. PubMed ID: 7047169
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The long-term effects of chlorpropamide on insulin, C-peptide, and proinsulin secretion.
    Elkeles RS, Heding LG, Paisey RB.
    Diabetes Care; 1982 Feb; 5(4):427-9. PubMed ID: 6759080
    [Abstract] [Full Text] [Related]

  • 6. Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.
    Pfeifer MA, Halter JB, Judzewitsch RG, Beard JC, Best JD, Ward WK, Porte D.
    Diabetes Care; 1984 Feb; 7 Suppl 1():25-34. PubMed ID: 6376026
    [Abstract] [Full Text] [Related]

  • 7. Hyaluronidase-induced inhibition of the insulinotropic action of sulfonylureas, leucine, and glucagon in rodent isolated pancreatic islets.
    Macchi IA, Zeytinoğlu FN.
    Horm Metab Res; 1976 Mar; 8(2):92-6. PubMed ID: 177348
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [C-peptide secretion dependent on serum glucose and insulin secretion - autoregulation of insulin secretion].
    Zilker T, Ermler R, Paterek K, Bottermann P.
    Verh Dtsch Ges Inn Med; 1976 Mar; 83():1385-8. PubMed ID: 347780
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Independent measures of insulin secretion and insulin sensitivity during the same test: the glucagon-insulin tolerance test.
    Dorkhan M, Tripathy D, Malm G, Asgharian H, Tuomi T, Groop L.
    J Intern Med; 2008 Jul; 264(1):62-71. PubMed ID: 18298489
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Failure of sulfonylureas to suppress plasma glucagon in man.
    Pek S, Fajans SS, Floyd JC, Knopf RF, Conn JW.
    Diabetes; 1972 Apr; 21(4):216-23. PubMed ID: 5017378
    [No Abstract] [Full Text] [Related]

  • 19. Overnight GLP-1 normalizes fasting but not daytime plasma glucose levels in NIDDM patients.
    Willms B, Idowu K, Holst JJ, Creutzfeldt W, Nauck MA.
    Exp Clin Endocrinol Diabetes; 1998 Apr; 106(2):103-7. PubMed ID: 9628239
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.